These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 12045347)

  • 1. New renin inhibitors with pseudodipeptidic units in P(1)-P(1') and P(2')-P(3') positions.
    Paruszewski R; Jaworski P; Winiecka I; Tautt J; Dudkiewicz J
    Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):850-3. PubMed ID: 12045347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions.
    Paruszewski R; Jaworski P; Bodnar M; Dudkiewicz-Wilczyńska J; Roman I
    Chem Pharm Bull (Tokyo); 2005 Oct; 53(10):1305-9. PubMed ID: 16204988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatically stable renin inhibitors containing statine and 6 aminohexanoic acid. Part IV.
    Paruszewski R; Jaworski P; Tautt J; Dudkiewicz J
    Boll Chim Farm; 1994 May; 133(5):301-8. PubMed ID: 8068237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1' position.
    Winiecka I; Marszałek D; Goldnik A; Jaworski P; Mazurek AP
    Pharmazie; 2014 Apr; 69(4):263-70. PubMed ID: 24791589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renin inhibitors containing statine and 6-aminohexanoic acid. Part III.
    Paruszewski R; Tautt J; Dudkiewicz J
    Pol J Pharmacol; 1993; 45(1):75-82. PubMed ID: 8401762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
    Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
    J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New potential renin inhibitors with dipeptide replacements in the molecule.
    Winiecka I; Dudkiewicz-Wilczyńska J; Roman I; Paruszewski R
    Acta Pol Pharm; 2010; 67(4):367-74. PubMed ID: 20635532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
    Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
    J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
    Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
    J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NEW RENIN-INHIBITORS--STABILITY AND ACTIVITY DETERMINATION. PART III.
    Marszałek D; Goldnik A; Winiecka I; Jaworski P; Mazurek AP
    Acta Pol Pharm; 2016; 73(2):329-36. PubMed ID: 27180425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New renin inhibitors--stability and activity determination. Part I.
    Marszałek D; Goldnik A; Mazurek AP; Winiecka I; Jaworskpi P
    Acta Pol Pharm; 2014; 71(4):545-53. PubMed ID: 25272881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a structurally modified phenylalanine residue to impart proteolytic stability.
    Plattner JJ; Marcotte PA; Kleinert HD; Stein HH; Greer J; Bolis G; Fung AK; Bopp BA; Luly JR; Sham HL
    J Med Chem; 1988 Dec; 31(12):2277-88. PubMed ID: 3143010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New renin inhibitors with hydrophilic C-terminus.
    Paruszewski R; Jaworski P; Winiecka I; Tautt J; Dudkiewicz J
    Pharmazie; 1999 Feb; 54(2):102-6. PubMed ID: 10084156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEW RENIN INHIBITORS - STABILITY AND ACTIVITY DETERMINATION. PART IV.
    Marszalek D; Goldnik A; Winiecka I; Jaworsk P; Mazurek Aleksander P
    Acta Pol Pharm; 2017 Mar; 74(2):393-399. PubMed ID: 29624244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New renin inhibitors--stability and activity determination. Part II.
    Marszałek D; Goldnik A; Mazurek AP; Winiecka I; Jaworski P; Szerszań S; Kozikowska E; Pawlik T
    Acta Pol Pharm; 2014; 71(4):555-61. PubMed ID: 25272882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
    Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
    J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship modeling of renin-inhibiting dipeptides.
    Udenigwe CC; Li H; Aluko RE
    Amino Acids; 2012 Apr; 42(4):1379-86. PubMed ID: 21246225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preparation, purification, and amino acid sequence of a polypeptide renin substrate.
    SKEGGS LT; KAHN JR; LENTZ K; SHUMWAY NP
    J Exp Med; 1957 Sep; 106(3):439-53. PubMed ID: 13463253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibitors: C-terminal oxetanes as potent transition-state mimics.
    Rosenberg SH; Spina KP; Stein H; Cohen J; Baker WR; Kleinert HD
    Bioorg Med Chem; 1994 Sep; 2(9):927-37. PubMed ID: 7712128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New inhibitors of human renin that contain novel Leu-Val replacements.
    Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
    J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.